Skip to main content
MUSTANG BIO, INC. logo

MUSTANG BIO, INC. — Investor Relations & Filings

Ticker · MBIO ISIN · US62818Q1040 LEI · 5493004W0VC1DPECQ779 US Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2023-04-28 Proxy Solicitation & In…
Country US United States of America
Listing US MBIO

About MUSTANG BIO, INC.

https://www.mustangbio.com/

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cell and gene therapies. The company's primary focus is on translating medical breakthroughs into potential cures for difficult-to-treat cancers and rare genetic diseases. Its pipeline is centered on Chimeric Antigen Receptor (CAR) T-cell therapies, a form of immunotherapy. Mustang Bio's strategy involves in-licensing promising technologies from academic institutions and advancing them through clinical trials, supported by its in-house manufacturing capabilities to ensure the production and delivery of these advanced treatments.

Recent filings

Filing Released Lang Actions
DEF 14A
Proxy Solicitation & Information Statement
2023-04-28 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 14, 2023, by Mustang Bio, Inc. It details an amendment to an At Market Issuance Sales Agreement related to the company's equity offering program. The content focuses on financing activities, specifically the continuation and terms of an at-the-market equity offering program, including the amount of shares to be issued and the agents involved. There are no financial statements or comprehensive financial performance data presented, nor is this a full annual or quarterly report. The document is not a report publication announcement or a certification but a regulatory filing disclosing a capital/financing update. Given the nature of the amendment to the sales agreement and the focus on equity issuance, the most appropriate classification is Capital/Financing Update (CAP). The document length (6758 characters) supports it being a substantive filing rather than a brief announcement. Confidence is high due to clear content and form type.
2023-04-20 English
424B5
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 1 to a Prospectus Supplement filed pursuant to Rule 424(b)(5) related to a Registration Statement on Form S-3. It discusses updates to the amount of shares eligible for sale under a Sales Agreement and references a reverse stock split. The document is a regulatory filing related to securities offering and amendments to prospectus supplements, not a financial report, earnings release, or management discussion. It is a typical capital markets disclosure updating offering terms and compliance with SEC rules. Therefore, it fits best under Capital/Financing Update (CAP). The document length (6534 characters) and content confirm it is a substantive amendment, not just a brief announcement or certification, supporting a high confidence classification as CAP.
2023-04-14 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. The content describes the termination of a material definitive agreement (a loan and security agreement) and the payoff of the loan. There are no financial statements or detailed financial data presented, nor is this an annual or quarterly report. The document is an announcement of a specific event related to financing activities, specifically the termination of a loan agreement and payoff. This fits the category of Capital/Financing Update (CAP). The document length is 3643 characters, which is consistent with a typical 8-K filing announcing a financing event. Therefore, the appropriate classification is CAP with high confidence.
2023-04-13 English
OWNERSHIP DOCUMENT
Director's Dealing
2023-04-06 English
OWNERSHIP DOCUMENT
Director's Dealing
2023-04-06 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.